Percutaneous dilatational tracheostomy (PDT) has become an integral part of airway management in the critical care setting and it is one of the most frequently performed procedures in critically ill patients. It has gained an increasing acceptance as an alternative to the classic operative tracheostomy and several prospective randomised trials [1] [2] [3] [4] have reported a lower incidence of complications with PDT compared to surgical tracheostomy. Chest X-ray (CXR) is routinely performed after tube placement and to detect potentially serious complications. A few studies have been performed to determine the usefulness of routine CXR following either surgical tracheostomy 5 or PDT performed under bronchoscopic guidance 6, 7 . However, PDT is also performed without bronchoscopic guidance. The yield of routine CXR after PDT performed without bronchoscopic guidance has not been examined before. Our hypothesis is that routine CXR after PDT performed without bronchoscopic guidance has a low diagnostic yield and leads to few changes in patient management. Therefore, we conducted this study to evaluate prospectively the yield of post-PDT CXR and to identify predictors of radiographic changes.
MATERIALS AND METHODS

Setting
This prospective cohort study was conducted in a 21-bed, tertiary care medical-surgical intensive care
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Patients
All consecutive patients older than 16 years who underwent PDT between May 2004 and December 2005 were included. An informed consent for PDT was obtained from all patients.
PDT techniques
PDTs were performed at the bedside by intensivists with a large cumulative experience of more than two-hundred PDTs, assisted by a critical care fellow or resident. The technique of PDT was either Ciaglia "single-step dilation" 8 using the Ultraperc Percutaneous Tracheostomy Kit (Smiths, Portex company; equivalent to the Ciaglia Blue Rhino) or Griggs 9 (Guide Wire Dilator Forceps: GWDF) using the Percutaneous Tracheostomy Kit (SimsPortex). All patients were sedated, pharmacologically paralysed and mechanically ventilated with 100% oxygen during the procedure. Regularly, PDT was performed without bronchoscopic guidance. However, bronchoscopy was used in selected patients such as in patients with cervical spine injury or with a short fat neck.
Pre-and post-PDT CXR
A CXR is performed, as daily routine, in the morning before PDT and another CXR is performed, as post-PDT.
Data collection
The following data were collected: patient demographics including age, gender, height and weight; admission categories (surgical, medical, trauma or burns); Acute Physiology and Chronic Health Evaluation III (APACHE III) scores 10 ; pre-PDT fraction of inspired oxygen (FiO 2 ) and positive endexpiratory pressure (PEEP); the use of bronchoscopic guidance and technique of PDT (Griggs "GWDF" or Ciaglia "single-step dilation"). We compared the postprocedure CXR with the last pre-procedure CXR and recorded any new changes including atelectasis, pneumothorax, pneumomediastinum, subcutaneous tube malposition, or para-tracheal tube placement.
including increase of PEEP, chest physiotherapy, therapeutic bronchoscopy, chest tube insertion, or tracheostomy tube repositioning.
Statistical analysis
We used Minitab for Windows (Minitab Inc., Release 12.1, State College, PA, U.S.A.) for statistical analysis. We used descriptive statistics to describe patients' baseline characteristics, post-PDT CXR changes and their impact on patient management. Continuous variables were described as mean and standard deviation (SD) and categorical variables were expressed as absolute and relative frequencies.
We used univariate analysis to identify predictors were entered into stepwise regression to identify independent predictors of CXR changes.
RESULTS
Baseline characteristics
Two-hundred-and-thirty-nine patients underwent PDT during the study period. The mean (±SD) age of patients was 54±22 years. Male patients totalled 185 (77.4%). The admission categories were as follows: medical 145 (61%), trauma 67 (28%), surgical 25 (10%) and burn 2 (1%). The mean (±SD) of APACHE III score was 79±29 (Table 1) . 
PDT data
The pre-PDT Table 2) .
Post-PDT CXR changes and impact on management
Atelectasis was the only new change detected on the post-procedure CXR and was found in 24 (10%) patients. In the remaining 215 (90%) patients, there in management included increase of PEEP (by 3 to 5 cmH 2 O) in six (2.5%) patients, chest physiotherapy in six (2.5%) patients and therapeutic bronchoscopy in two (1%) patients. Table 3 shows the results of univariate analysis of predictors of post-procedure CXR changes. Trauma and pre-PDT PEEP >5 cmH 2 O were predictors of post-tracheostomy CXR changes (OR=4.28, 95% CI=1.80-10.20, P=0.001 and OR=3.01, 95% CI=1.27-7.15, P=0.013, respectively). However, age and medical admissions were associated with lower incidence of post-procedure CXR changes (OR=0.97 for each year of age, 95% CI=0.95-0.99, P=0.002; and OR=0.35, 95% CI=0.15-0.83, P=0.018, respectively). The following variables a decrease in the incidence of post-procedure CXR changes: gender, surgical reason for ICU admission, APACHE III score, pre-PDT FiO 2 >0.4, technique of PDT, bronchoscopy use, or the occurrence of perioperative complications. Using stepwise regression of predictors of post-procedure CXR changes, only trauma and pre-PDT PEEP >5 cmH 2 O CXR changes ( Table 4 ). The incidence of postprocedure CXR changes was 3% in non-trauma 2 The incidence of perioperative complications with PDT has ranged in different studies from 3 to 18% [11] [12] [13] [14] [15] [16] . Several tools have been suggested to minimise the incidence and severity of complications and to improve the safety of PDT such as bronchoscopic guidance and post-procedure CXR. Studies have demonstrated that bronchoscopic monitoring during PDT facilitates the procedure and reduces potential complications, hence providing a higher degree of safety [16] [17] [18] [19] [20] [21] [22] . However, bronchoscopic guidance is not always necessary and a growing body of literature supports the safety of performing PDT without bronchoscopic guidance 11, . Studies reported complications of PDT performed with or without bronchoscopy 11 . The complications that would be detected on the post-procedure CXR following PDT include atelectasis, pneumothorax, pneumomediastinum, positioning and paratracheal tube placement. However, recently, the value of routine posttracheostomy CXR has been challenged as well as its impact on patient management.
Predictors of post-procedure CXR changes
Few studies have examined the value of routine post-procedure CXR following PDT performed under bronchoscopic guidance. Datta et al 6 , in a retrospective study, examined the usefulness of routine CXR following PDT performed under bronchoscopic visualisation. In two (3.3%) of the 60 patients, postoperative complications were detected on the post-procedure CXR, one with a pneumomediastinum that was treated conservatively and the other with a tension pneumothorax that was treated with a chest tube insertion. In both cases, the physician anticipation of complications. However, it is unclear whether the investigators examined only for those who had CXR changes. The authors concluded that CXR is not necessary after PDT if performed under bronchoscopic guidance unless and the small number of patients make the conclusion Datta, our study did not show that bronchoscopic guidance during PDT reduces the incidence of CXR changes, or that there is an association between perioperative complications and occurrence of post-PDT CXR changes. Based on the above, the decision to perform CXR after PDT cannot be made on whether bronchoscopy was used or not, nor on
Recently, Hoehne et al 27 , in a retrospective study of 73 patients, evaluated the utility of CXR after PDT performed with bronchoscopic guidance. The study detected no complication on the post-PDT CXR in the 73 patients. Again, the retrospective nature and the small number of patients might have underestimated the incidence of post-PDT CXR changes.
Nevertheless, it is important to note that serious and life-threatening complications of PDT such as paratracheal tube placement are usually selfevident and should be recognised clinically and managed instantly prior to a CXR being performed. Consequently, CXR is not the standard tool for the diagnosis of such life-threatening complications. Conversely, other complications such as atelectasis until the next-day CXR might not have a major consequence.
Our study advances the clinical management of the post-PDT patients in important ways, as well as complementing current literature. Along with other studies, it demonstrated that routine CXR following tracheostomy, whether surgical 5 or PDT performed with 6, 27 or without bronchoscopic guidance, is probably unnecessary and selective use may be more appropriate. The question is what are the criteria to perform a CXR after tracheostomy? Our study provided some clues to such a decision. In trauma explained by the fact that trauma patients who require tracheostomy are at high risk of developing respiratory complications for several reasons including loss of ability to clear the bronchial tree (intense analgesia and sedation) leading to retention of secretions and formation of mucous plugs with resultant atelectasis. Moreover, trauma has been development of nosocomial pneumonia 28, 29 . We also found that PEEP >5 cmH 2 predictor of CXR changes after PDT. This is probably related to alveolar collapse and derecruitment due to the loss of PEEP after tracheal opening and dilatation.
This study has a number of strengths including the prospective nature, the inclusion of all consecutive patients and the large number of patients. As a potential limitation, the study was observational and was conducted in a single centre.
CONCLUSIONS
Post-procedure CXR following PDT performed without bronchoscopic guidance has a low diagnostic yield, detecting mainly atelectasis and leading to a change in the management in a minority of patients. Routine CXR after apparently uncomplicated PDT performed by an experienced operator may not be necessary and selective use may improve its diagnostic and clinical yield and reduce the risk of pre-PDT PEEP >5 cmH 2 O as independent predictors of post-procedure CXR changes. Further studies are required to validate the safety of selective versus routine use of post-procedure CXR following PDT performed without bronchoscopic guidance.
